Skip to content

Clinical trials

Phase 3 Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Clear all

207 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
200210
200311
200426
200522
200618
20079
200811
200912
20109
20116
20126
20135
20144
20155
20167
20172
20184
20193
20202
20212
20221
20231
20245
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed162
Terminated18
Recruiting10
Unknown status7
Withdrawn5
Active, not recruiting3
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca16
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.16
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.12
Otsuka Pharmaceutical Development & Commercialization, Inc.9
University Hospitals Cleveland Medical Center9
Intra-Cellular Therapies, Inc.8
Organon and Co8
Sumitomo Pharma America, Inc.8
GlaxoSmithKline7
Lindner Center of HOPE7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder207
Mania34
Schizophrenia15
Psychotic Disorders14
Major Depressive Disorder11
Mood Disorders6
Affective Disorders, Psychotic5
Depressive Disorder3
Mental Disorders3
Psychomotor Agitation3

Trials

Showing 1 to 25 of 207. Each trial links to its page on Pharma Observatory.

107 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.